Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992

Acta Psychiatrica Scandinavica

Volumn 96, Issue 3, 1997, Pages 169-175

  Fugelstad, A ^a,c   Annell, A ^b   Rajs, J ^b   Agren G ^b  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Psykiatriska Beroendekliniken St G   (Sweden)

Author keywords

Heroin addiction; HIV infection; Longitudinal study; Methadone treatment; Substance abuse

Indexed keywords

AMPHETAMINE DERIVATIVE; DIAMORPHINE; METHADONE;

ARTICLE; CAUSE OF DEATH; DRUG DEPENDENCE; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MORTALITY; PRIORITY JOURNAL; SWEDEN;

EID: 0030879955     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb10147.x     Document Type: Article

References (18)

1. GOLDBERG, L. Drug abuse in Sweden. Bull Narcotics 1968: 20: 1-31.
2. BEJEROT N. Addiction and society. Springfield, IL: Charles C. Thomas, 1970.
3. BYQVISI S, GOMHR G, OLSSON O. Det tunga narkotikamissbrukets omfattning i Stockholms län 1992 (Extent of heavy drug abuse in Stockholm in 1992). Stockholm: Centralförbundet för Alkohol- och Narkotikaupplysning, 1993.
4. PEHRSON PO, GAINES H, GYLLENSTEN K et al. HIV infection among i.v. drug users in Stockholm (Abstract 4510). Fourth International Conference on AIDS, Stockholm, 1988.
5. KÄLL KL, OLIN RG. HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. AIDS 1990: 4: 153-157.
6. GUNNE LM, GRÖNBLADH L. The Swedish methadone maintenance program: a controlled study. Drug Alcohol Dep 1981: 7: 249-256.
7. GRÖNBLADH L, ÖHLUND LS, GUNNE LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand 1990: 82: 223-227.
8. FUGELSTAD A, RAJS J, Bo M, GERHARDSSON DE VERDIER M. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction 1995: 90: 711-716.
9. VAILLANT GE. A 20-year follow-up of New York narcotic addicts. Arch Gen Psychiatry 1973: 29: 237-241.
10. TUNVING K. Fatal outcome in drug addiction. Acta Psychiatr Scand 1988: 77: 229-232.
11. TUNVING K, OLSSON B, KRANTZ P, ed. Dödligheten bland narkotikamissbrukare i de nordiska länderna (Mortality among drug abusers in the Nordic countries). Stockholm: Centralförbundet för alkohol- och narkotikaupplysning, 1989.
12. ENGSTRÖM A, ADAMSSON C, ALLEBECK P, RYDBERG U. Mortality in patients with substance abuse. Int J Addict 1991: 26: 91-106.
13. HAASTRUP S, JEPSEN PW. Eleven-year follow-up of 300 young opioid addicts. Acta Psychiatr Scand 1988: 77: 22-26.
14. ESKILD A, MAGNUS P, SAMUELSEN SO, SOHLBERG C, KITTELSEN P. Mortality and causes of death among intravenous drug addicts in Oslo. Tidsskrift Den Norske Laegeforening 1993: 113: 1331-1333.
15. SAELAN H. Dödsfald blandt stofmisbrugere (Causes of death amoung drug abusers). Alkohol- och narkotikamisbruget 1995. Copenhagen: Sundhedsstyrelsen, 1995.
16. PUSCHEL K, LOCKEMANN U, SCHNEIDER V et al. HIV-1 prevalence among drug deaths in major cities of central and northern Europe. Forens Sci Int 1992: 57: 57-62.
17. LOCKEMAN U, WISCHHUSEN F, PÜSCHEL K. Vergleich der HIV-1-Prävalenz bei Drogentodesfällen in Deutschland sowie in verschidenen europäische Grosstädten (Stand 31.12.1993) [Comparison of the HIV-1 prevalence of drug abuse-related fatalities in Germany and in other European cities (up to 31 December 1993)]. Aids-forschung AIFO 1995: 10: 253-256.
18. ESKILD A, MAGNUS P, SAMUELSEN SO, SOHLBERG C, KITTELSEN P. Differences in mortality rates and causes of death between HIV-positive and HIV-negative intravenous drug users. Int J Epidemiol 1993: 22: 315-320.